Similar articles for PMID: 32646876

Year	Number of Results
1940	1
1998	1
2002	1
2004	1
2006	2
2007	1
2008	2
2009	3
2010	5
2011	5
2012	5
2013	7
2014	7
2015	6
2016	7
2017	13
2018	11
2019	15
2020	21
2021	17
2022	14
2023	5
2024	0

1

Voxelwise and Patientwise Correlation of ¹⁸F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular Subtypes.

Tatekawa H, Hagiwara A, Yao J, Oughourlian TC, Ueda I, Uetani H, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. Tatekawa H, et al. J Nucl Med. 2021 Mar;62(3):319-325. doi: 10.2967/jnumed.120.247411. Epub 2020 Jul 9. J Nucl Med. 2021. PMID: 32646876 Free PMC article.

2

Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas.

Karavaeva E, Harris RJ, Leu K, Shabihkhani M, Yong WH, Pope WB, Lai A, Nghiemphu PL, Liau LM, Chen W, Czernin J, Cloughesy TF, Ellingson BM. Karavaeva E, et al. Mol Imaging Biol. 2015 Jun;17(3):434-42. doi: 10.1007/s11307-014-0807-3. Mol Imaging Biol. 2015. PMID: 25465392 Free article.

3

Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study.

Tatekawa H, Yao J, Oughourlian TC, Hagiwara A, Wang C, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Salamon N, Ellingson BM. Tatekawa H, et al. Clin Nucl Med. 2020 Dec;45(12):e505-e511. doi: 10.1097/RLU.0000000000003318. Clin Nucl Med. 2020. PMID: 33031233 Free PMC article.

4

Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.

Lee MK, Park JE, Jo Y, Park SY, Kim SJ, Kim HS. Lee MK, et al. Eur Radiol. 2020 Feb;30(2):844-854. doi: 10.1007/s00330-019-06395-2. Epub 2019 Aug 24. Eur Radiol. 2020. PMID: 31446467

5

Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomas.

Tatekawa H, Hagiwara A, Uetani H, Yao J, Oughourlian TC, Bahri S, Wang C, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. Tatekawa H, et al. J Neurooncol. 2020 Sep;149(2):337-346. doi: 10.1007/s11060-020-03613-6. Epub 2020 Sep 14. J Neurooncol. 2020. PMID: 32929644 Free PMC article.

6

Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.

Leu K, Ott GA, Lai A, Nghiemphu PL, Pope WB, Yong WH, Liau LM, Cloughesy TF, Ellingson BM. Leu K, et al. J Neurooncol. 2017 Aug;134(1):177-188. doi: 10.1007/s11060-017-2506-9. Epub 2017 May 25. J Neurooncol. 2017. PMID: 28547590 Free PMC article.

7

Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.

Rossi Espagnet MC, Romano A, Mancuso V, Cicone F, Napolitano A, Scaringi C, Minniti G, Bozzao A. Rossi Espagnet MC, et al. Br J Radiol. 2016 Oct;89(1066):20160476. doi: 10.1259/bjr.20160476. Epub 2016 Aug 9. Br J Radiol. 2016. PMID: 27505026 Free PMC article.

8

¹⁸F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study.

Patel CB, Fazzari E, Chakhoyan A, Yao J, Raymond C, Nguyen H, Manoukian J, Nguyen N, Pope W, Cloughesy TF, Nghiemphu PL, Czernin J, Lai A, Ellingson BM. Patel CB, et al. J Neurooncol. 2018 Sep;139(2):399-409. doi: 10.1007/s11060-018-2877-6. Epub 2018 Apr 20. J Neurooncol. 2018. PMID: 29679199 Free PMC article.

9

Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas.

Hong EK, Choi SH, Shin DJ, Jo SW, Yoo RE, Kang KM, Yun TJ, Kim JH, Sohn CH, Park SH, Won JK, Kim TM, Park CK, Kim IH, Lee ST. Hong EK, et al. Korean J Radiol. 2021 Feb;22(2):233-242. doi: 10.3348/kjr.2020.0011. Epub 2020 Sep 10. Korean J Radiol. 2021. PMID: 32932560 Free PMC article.

10

Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.

Kong Z, Yan C, Zhu R, Wang J, Wang Y, Wang Y, Wang R, Feng F, Ma W. Kong Z, et al. Neuroimage Clin. 2018 Jul 5;20:51-60. doi: 10.1016/j.nicl.2018.07.001. eCollection 2018. Neuroimage Clin. 2018. PMID: 30069427 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

123 results

Results by year